These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29179687)

  • 61. Clostridium difficile and cystic fibrosis: management strategies and the role of faecal transplantation.
    Dunwoody R; Steel A; Landy J; Simmonds N
    Paediatr Respir Rev; 2018 Mar; 26():16-18. PubMed ID: 28411069
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply.
    Ianiro G; Sanguinetti M; Gasbarrini A; Cammarota G
    Clin Microbiol Infect; 2017 Nov; 23(11):891. PubMed ID: 28502839
    [No Abstract]   [Full Text] [Related]  

  • 63. Fecal Microbiota Therapy as Rescue Therapy for Life-Threatening Clostridium difficile Infection in the Critically Ill: A Small Case Series.
    Schulz-Stübner S; Textor Z; Anetseder M
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1129-31. PubMed ID: 27452730
    [No Abstract]   [Full Text] [Related]  

  • 64. [Faecal microbiota transplantation in France: what applicable law?].
    Megerlin F; Fouassier E
    Ann Pharm Fr; 2014 Sep; 72(5):363-74. PubMed ID: 25220232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. "Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year cohort study"; methodological issues.
    Ayubi E; Safiri S
    Clin Microbiol Infect; 2017 Nov; 23(11):890. PubMed ID: 28442436
    [No Abstract]   [Full Text] [Related]  

  • 66. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
    Weingarden AR; Vaughn BP
    Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of fecal microbiota transplantation suitable for mainstream medicine.
    Khoruts A; Sadowsky MJ; Hamilton MJ
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fecal Transplantation for Clostridium Difficile-"All Stool May Not Be Created Equal".
    Gathe JC; Diejomaoh EM; Mayberry CC; Clemmons JB
    J Int Assoc Provid AIDS Care; 2016; 15(2):107-8. PubMed ID: 26821578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Faecal transplants for children with recurrent infections].
    Ooijevaar RE; van Rossen TM; Vandenbroucke-Grauls CMJE; Budding AE; Kneepkens CMF; de Meij TGJ
    Ned Tijdschr Geneeskd; 2019 Jul; 163():. PubMed ID: 31361420
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.
    Walia R; Garg S; Song Y; Girotra M; Cuffari C; Fricke WF; Dutta SK
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):565-70. PubMed ID: 25023578
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Editorial: faecal microbiota transplantation-the silver bullet for severe and fulminant Clostridioides difficile infection?
    Costello SP; Bryant RV
    Aliment Pharmacol Ther; 2020 Jan; 51(1):180-181. PubMed ID: 31850561
    [No Abstract]   [Full Text] [Related]  

  • 72. Donor faecal transplantation is highly curative in recurrent C difficile infection, trial finds.
    Mayor S
    BMJ; 2016 Aug; 354():i4638. PubMed ID: 27558248
    [No Abstract]   [Full Text] [Related]  

  • 73. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
    Kelly CR; Kahn S; Kashyap P; Laine L; Rubin D; Atreja A; Moore T; Wu G
    Gastroenterology; 2015 Jul; 149(1):223-37. PubMed ID: 25982290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
    Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
    Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
    Newman KM; Rank KM; Vaughn BP; Khoruts A
    Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
    Allegretti JR; Mullish BH; Kelly C; Fischer M
    Lancet; 2019 Aug; 394(10196):420-431. PubMed ID: 31379333
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Faecal microbiota transplantation for Clostridium difficile infection resulting in a decrease in psoriatic arthritis disease activity.
    Selvanderan SP; Goldblatt F; Nguyen NQ; Costello SP
    Clin Exp Rheumatol; 2019; 37(3):514-515. PubMed ID: 30943129
    [No Abstract]   [Full Text] [Related]  

  • 78. Faecal microbiota transplantation in clinical practice.
    Cammarota G; Ianiro G; Gasbarrini A;
    Gut; 2018 Jan; 67(1):196-197. PubMed ID: 28381525
    [No Abstract]   [Full Text] [Related]  

  • 79. Faecal microbiota transplantation donor stools need screening for poliovirus.
    Speck PG; Mitchell JG
    Gut; 2018 Aug; 67(8):1559-1560. PubMed ID: 29030396
    [No Abstract]   [Full Text] [Related]  

  • 80. Obstacles to establishing an NHS faecal transplant programme.
    Mullish BH; Williams HR
    BMJ; 2015 Nov; 351():h6043. PubMed ID: 26585376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.